Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof
US11897959B2 · kind B2 · utility
1Cited by
68References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2021 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Jan 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antibody or antibody fragment having a heavy chain variable region and/or light chain variable region that specifically binds to Axl protein. Immuoconjugages, pharmaceutical compositions and kits comprising the antibodies and antibody fragments are also provided. Also disclosed are methods of treating Axl-expressing cancers using the antibodies, antibody fragments, immunoconjugates and pharmaceutical compositions of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.